Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice

Pediatric Research

Volumn 69, Issue 1, 2011, Pages 56-61

  Fan, Xiyong ^a,b   Heijnen, Cobi J ^a   Van Der Kooij, Michael A ^a   Groenendaal, Floris ^a   Van Bel, Frank ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ATROPHY; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DRUG EFFECT; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SENSORIMOTOR FUNCTION; STEM CELL; SUBVENTRICULAR ZONE; WHITE MATTER;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FEMALE; HIPPOCAMPUS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MALE; MICE; MYELIN BASIC PROTEINS; MYELIN SHEATH; NEUROGENESIS; PSYCHOMOTOR PERFORMANCE; SEX FACTORS; TIME FACTORS;

EID: 78650808369     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181fcbef3     Document Type: Article

References (44)

1. Ferriero DM 2004 Neonatal brain injury. N Engl J Med 351:1985-1995
2. Hagberg B, Hagberg G, Olow I 1993 The changing panorama of cerebral palsy in Sweden. VI. Prevalence and origin during the birth year period 1983-1986. Acta Paediatr 82:387-393
3. Van Bel F, Groenendaal F 2008 Long-term pharmacologic neuroprotection after birth asphyxia: where do we stand? Neonatology 94:203-210
4. Gonzalez FF, Ferriero DM 2008 Therapeutics for neonatal brain injury. Pharmacol Ther 120:43-53
5. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D 2010 Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic enceph-alopathy: synthesis and meta-analysis of trial data. BMJ 340:c363
6. Azzopardi D, Edwards AD 2007 Hypothermia. Semin Fetal Neonatal Med 12:303-310
7. Carnot P, Deflandre C 1906 [Haemopoietic activity of the serum in blood regeneration]. C R Acad Sci Paris 143:432-435
8. Van Der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, Van Bel F 2008 Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 59:22-33
9. Ehrenreich H, Degner D, Meller J, Brines M, Béhé M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Brück W, Rüther E, Cerami A, Becker W, Sirén AL 2004 Erythropoietin: a candidate compound for neuropro-tection in schizophrenia. Mol Psychiatry 9:42-54
10. Sun Y, Calvert JW, Zhang JH 2005 Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36:1672-1678
11. Kellert BA, McPherson RJ, Juul SE 2007 A comparison of high-dose recombi-nant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res 61:451-455
12. Shingo T, Sorokan ST, Shimazaki T, Weiss S 2001 Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:9733-9743
13. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M 2004 Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35:1732-1737
14. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M 1995 Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720
15. Rabie T, Marti HH 2008 Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 23:263-274
16. Sola A, Wen TC, Hamrick SE, Ferriero DM 2005 Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 57:110R-117R
17. Van Der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, Van Bel F 2009 Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia- induced brain injury in the neonatal rat? Neurosci Lett 451:109-113
18. Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, Guiba-Tziampiri O 2005 Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045:22-30
19. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE 2008 A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122:383-391
20. Bierer R, Peceny MC, Hartenberger CH, Ohls RK 2006 Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118:e635-e640
21. Fauchère JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M, Bucher HU 2008 An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 122:375-382
22. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K, Wang X 2009 Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124:e218-e226
23. Van Der Kooij MA, Ohl F, Arndt SS, Kavelaars A, Van Bel F, Heijnen CJ 2010 Mild neonatal hypoxia-ischemia induces long-term motor- and cognitive impairments in mice. Brain Behav Immun 24:850-856
24. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, Van Bel F, Heijnen CJ 2007 Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab 27:282-292
25. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST 2000 CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787
26. Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, McQuillen PS, Ferriero DM 2005 Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58:106-111
27. Scholzen T, Gerdes J 2000 The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311-322
28. Bona E, Hagberg H, Løberg EM, Bågenholm R, Thoresen M 1998 Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 43:738-745
29. Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A 2006 Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 139:803-811
30. Hurn PD, Vannucci SJ, Hagberg H 2005 Adult or perinatal brain injury: does sex matter? Stroke 36:193-195
31. Zeng SM, Yankowitz J, Widness JA, Strauss RG 2001 Etiology of differences in hematocrit between males and females: sequence-based polymorphisms in erythro-poietin and its receptor. J Gend Specif Med 4:35-40
32. Juul SE, Stallings SA, Christensen RD 1999 Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 46:543-547
33. Bührer C, Felderhoff-Mueser U, Wellmann S 2007 Erythropoietin and ischemic conditioning-why two good things may be bad. Acta Paediatr 96:787-789
34. Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE 2007 Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 61:671-675
35. Weber A, Dzietko M, Berns M, Felderhoff-Mueser U, Heinemann U, Maier RF, Obladen M, Ikonomidou C, Bührer C 2005 Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol Dis 20:594-600
36. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M 2001 Increased cerebral infarct volumes in polyglobulic mice overexpressing eryth-ropoietin. J Cereb Blood Flow Metab 21:857-864
37. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A 2004 Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 101:14907-14912
38. Walrafen P, Verdier F, Kadri Z, Chrétien S, Lacombe C, Mayeux P 2005 Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105:600-608
39. Rice JE III, Vannucci RC, Brierley JB 1981 The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141
40. Ditelberg JS, Sheldon RA, Epstein CJ, Ferriero DM 1996 Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 39:204-208
41. McAuliffe JJ, Miles L, Vorhees CV 2006 Adult neurological function following neonatal hypoxia-ischemia in a mouse model of the term neonate: water maze performance is dependent on separable cognitive and motor components. Brain Res 1118:208-221
42. Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J 2007 Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 38:2795-2803 (Pubitemid 47494020)
43. Campana WM, Misasi R, O'Brien JS 1998 Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1:235-241
44. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, Ferriero DM 2007 Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29:321-330